Amantadine for the Treatment of Behavioral Disturbance in Frontotemporal Dementia (FTD)
Status:
Withdrawn
Trial end date:
2007-07-26
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to test whether or not the medication amantadine is
effective in reducing behavioral disturbances in patients with frontotemporal dementia.